TL;DR: After 12 weeks, the topical 10% vitamin C serum group showed lower measured yellowness and redness, alongside improvements in glycation, carbonylation, inflammation, and antioxidant-capacity markers. In mirror terms, the visible endpoints point most directly to a less yellow and less red-looking complexion—not proof of wrinkle reversal, lifting, or confirmed dark-spot fading
Bottom line for your skin: Most relevant to uneven tone, dullness, and visible brightness, with the caveat that pigment outcomes need human-use confirmation
Each row is one measured skin endpoint from this paper. Bars compare numeric magnitudes only within this post; they are not a cross-study ranking and they do not make different scales interchangeable.
Key Outcomes / Results
| Outcome | Reported result | How to read it |
|---|---|---|
| Yellowness | Skin b* value decreased 6.13% after 12 weeks; p<0.001 | Relevant to dullness and uneven tone; the important question is whether people can see the color shift. |
| Redness | Skin a* value decreased 16.46% after 12 weeks; p<0.001 | Relevant to visible redness or irritation, depending on how the study measured it. |
| Glycation marker | AGEs reduced 17.65% after 12 weeks; p<0.001 | Aging-marker signal, not a direct wrinkle or firmness score. Treat it as supportive biology. |
| Inflammation marker | IL-1alpha content dropped 58.73% after 12 weeks; p<0.001 | Inflammation-marker signal. It may support calmer-looking skin, but it is not the same as a clinical redness score. |
The Study
Study on the Multiple Efficacies of Vitamin C Serum in Anti-Glycation, Anti-Carbonylation, Antioxidation, and Anti-Inflammation of Human Skin Based on In Vivo Tests.
Journal: Journal of cosmetic dermatology
Published: 2026 May
Authors: Zi Y, Liu J, Liu Q, Pan Y, et al.
Design in plain English: This was not a single-arm before/after test. It was a 12-week randomized, double-blind, controlled human trial. In practical terms, 66 healthy Chinese women were assigned to one of two groups: 35 used the topical 10% vitamin C serum and 31 were in the blank/control group. That matters because the serum group was compared with a control group, which is stronger than simply measuring one group before and after. It still applies most directly to this exact formula, this study population, and this 12-week use pattern.
Dermatologist/Researcher Interpretation
The most customer-relevant findings are the skin color measurements. After 12 weeks, skin b* value decreased 6.13%; p<0.001, and skin a* value decreased 16.46%; p<0.001. In plain language, b* reflects yellow tone and a* reflects red tone, so these changes could translate in the mirror as skin that looks less yellow, less red, and potentially brighter or more even.
The design makes the result more useful than a simple single-arm study. Randomized means participants were assigned to a study group rather than choosing their own treatment. Double-blind means the measurement process was designed to reduce expectation bias. Controlled means there was a comparison group. For a skincare customer, that makes the tone and redness findings more credible than a before/after selfie series, while still not proving every vitamin C product will perform the same way.
This was finished-formula evidence, not just ingredient theory. Participants in the topical group used a 10% vitamin C serum for 12 weeks. The topical formulation contained 10% VC as the sole active ingredient, with a vehicle of water, propylene glycol, pentylene glycol, and glycerin. It was prepared as a powder vehicle dual chamber system, with VC powder stored separately from the liquid vehicle and mixed by participants immediately before each use
Beyond visible color, the study also measured aging-related biological markers in skin. AGEs reduced 17.65% after 12 weeks; p<0.001, carbonylation fluorescence intensity decreased by 49.22%, IL-1alpha content dropped 58.73% after 12 weeks; p<0.001, and ABTS free radical scavenging rate increased by 12.14%. These endpoints support the idea that the formula affected glycation, protein carbonylation, inflammation, and antioxidant capacity in vivo
What this could mean by feel or appearance is a complexion that appears less dull or yellow-toned and less visibly red after consistent use. However, the study’s reported visible endpoints were instrumental skin color parameters, not a direct consumer rating of glow, softness, wrinkles, sagging, pores, or dark spots. The biomarker improvements are interesting and biologically relevant, but they do not by themselves prove visible firming or wrinkle reduction
What this means for product claims
A fair claim would be: in a 12-week randomized, double-blind, controlled trial in healthy Chinese females, a topical 10% vitamin C serum improved measured skin yellowness and redness and improved several aging-related skin biomarkers. A stronger claim—such as proven wrinkle reversal, lifting, or confirmed treatment of hyperpigmentation—goes beyond the reported endpoints
Key limitations
- The completed study population was 66 healthy Chinese females, with 31 in the blank group and 35 in the topical group, so the findings may not automatically generalize to all sexes, ethnicities, ages, or skin conditions
- The study duration was 12 weeks; it does not establish longer-term maintenance or what happens after stopping use
- The visible outcomes reported here were skin b* value and skin a* value. The study does not establish changes in wrinkles, sagging, pores, or consumer-perceived radiance as separate endpoints
- The evidence is for this topical 10% vitamin C serum format and use pattern, not for every vitamin C product or every vitamin C derivative
- Biomarker changes in AGEs, carbonylation fluorescence intensity, IL-1alpha, and ABTS free radical scavenging rate are supportive mechanistic evidence, but they should not be treated as direct proof of every anti-aging cosmetic benefit
Reference: Zi Y, Liu J, Liu Q, Pan Y, et al. Study on the Multiple Efficacies of Vitamin C Serum in Anti-Glycation, Anti-Carbonylation, Antioxidation, and Anti-Inflammation of Human Skin Based on In Vivo Tests.. Journal of cosmetic dermatology. 2026 May. doi: 10.1111/jocd.70888. PMID: 42087444.